Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation — Stella

Recruiting

Back to Poliomyelitis trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

Panama

Cevaxin - 24 de Diciembre, Panama City

Cevaxin - Ave. México, Panama City

Cevaxin - Chorrera, Panama City

Key details

Phase

Safety & dosing

Sponsor

PATH

Collaborators

Bill and Melinda Gates Foundation, PT Bio Farma

Enrollment target

~675 participants

Started

November 2025

Primary completion

December 2026

Age range

6 Weeks – 7 Weeks

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov